EPRX
EupraxiaDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
EPRX vs peer average
37/100
EPRX vs. peer average (D vs. C)
Grade spread
B 4 · C 1 · D 4 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
PRTA is the first available peer comparator.
Loose same-sector market-cap proxy from the packet; no direct clinical or indication comparability was established.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
EPRX
Eupraxia
PRTA
Prothena
Grade
D
D
Momentum
48
56
Value
41
41
Sentiment
49
58
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs PRTA
EPRX / PRTA
Grade Position
Below peers
EPRX vs. peer average (D vs. C)
37/100
Momentum
48
PRTAValue
41
EPRXSentiment
49
PRTARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs EPRX
PRTA is the first peer returned for this comparison set.